Vallon Pharmaceuticals (VLON) News Today → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free VLON Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsInsider TradesSocial MediaStock AnalysisCompetitorsInsider TradesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQuestcor Pharmaceuticals,forbes.com - July 21 at 11:15 PMVallon Pharmaceuticals' shareholders approve reverse merger with California companybizjournals.com - April 20 at 11:09 PMVallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Splitfinance.yahoo.com - April 20 at 11:09 PMVallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until April 20, 2023finance.yahoo.com - April 12 at 5:20 PMLab Notes: CHOP gets $10M research gift; Vallon seeks greater shareholder support for mergerbizjournals.com - April 7 at 3:29 PMVallon Pharmaceuticals Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio and Urges Stockholders of Record as of March 6, 2023 to Vote by April 11, 2023, at 11:59 PM ETfinance.yahoo.com - April 4 at 1:30 PMVallon Pharmaceuticals Inc.: Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Resultsfinanznachrichten.de - February 24 at 6:18 PMVallon Pharmaceuticals Reports Fiscal Year 2022 Financial Resultsfinance.yahoo.com - February 24 at 8:19 AMIs Vallon Pharmaceuticals Inc (VLON) recent surge justifiedbenzinga.com - February 14 at 6:48 PMmarketbeat.com - February 13 at 9:36 AMVallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Eventfinance.yahoo.com - January 11 at 9:46 AMSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vallon Pharmaceuticals, Inc. - VLONbenzinga.com - December 27 at 6:38 PMVallon Pharmaceuticals to merge with California biotech firm in 'best path forward'bizjournals.com - December 14 at 12:21 PMWhat's Going On With Vallon Pharmaceuticals Stock Today?msn.com - December 14 at 12:21 PMWhy Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarketbenzinga.com - December 14 at 7:15 AMVallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulatorsfinance.yahoo.com - December 13 at 4:19 PMmarketbeat.com - December 13 at 4:06 PMVallon Pharmaceuticals Reports Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 3 at 8:06 PMVallon Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - July 28 at 12:15 PMVallon Pharmaceuticals, Inc. (VLON)finance.yahoo.com - July 20 at 12:07 AMVallon Pharmaceuticals plans $3.9M stock sale to support exploration of strategic alternativesbizjournals.com - May 16 at 8:29 PMVallon Pharmaceuticals to raise $3.9M in stock offeringseekingalpha.com - May 13 at 4:14 PMVallon Pharmaceuticals Announces $3.9 Million Registered Direct Offeringfinance.yahoo.com - May 13 at 4:14 PMVallon Pharma Posts Additional Data From SEAL Study Of Formulated CNS Stimulantfinance.yahoo.com - May 12 at 3:50 PMVallon Pharmaceuticals Reports Additional Pharmacokinetic and Pharmacodynamic Data from SEAL Study of ADAIRfinance.yahoo.com - May 12 at 10:50 AMVallon Pharmaceuticals Announces Issuance of Japanese Patent Covering Composition of Matter and Methods of Manufacturing for ADAIRfinance.yahoo.com - May 11 at 1:44 PMVallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - May 9 at 6:21 PMVallon Pharma Up 85% In Pre-market On Exploring Strategic Alternativesmarkets.businessinsider.com - April 22 at 2:26 PMVallon stock surges on review of strategic alternativesseekingalpha.com - April 22 at 2:26 PMVallon Shares Soar Premarket After Company Hangs 'For Sale' Sign >VLONmarketwatch.com - April 22 at 2:26 PMVallon Pharmaceuticals stock skyrockets after move to 'evaluate strategic alternatives'bizjournals.com - April 22 at 2:26 PMWhy Are Vallon Pharma Shares Surging Todayfinance.yahoo.com - April 22 at 2:26 PMVallon Pharmaceuticals Announces Review of Strategic Alternativesfinance.yahoo.com - April 22 at 8:10 AMVallon (VLON) Plummets as ADAIR Study Misses Primary Goalnasdaq.com - March 22 at 6:53 PMMid-Afternoon Market Update: Dow Tumbles 300 Points; Vallon Pharmaceuticals Shares Plungemarkets.businessinsider.com - March 21 at 5:53 PMVallon says its abuse-deterrent ADHD drug candidate didn't work in a clinical trialmorningstar.com - March 21 at 12:47 PMVallon crashes after lead program for ADHD candidate did not meet main goalseekingalpha.com - March 21 at 12:47 PMWhy Vallon Pharma Stock Falling In Pre-market?nasdaq.com - March 21 at 12:47 PMVallon Pharmaceuticals stock plunges 70% after ADHD drug candidate misses primary endpointfinance.yahoo.com - March 21 at 12:47 PMVallon Pharmaceuticals Announces Topline Results of its Pivotal SEAL Study for Lead Program, ADAIR, for the Treatment of ADHDfinance.yahoo.com - March 21 at 7:47 AMmarketbeat.com - March 21 at 6:59 AMVallon Pharmaceuticals Announces Appointment of Meenu Karson to Board of Directorsfinance.yahoo.com - February 28 at 4:58 PMVallon Pharmaceuticals Announces Issuance of U.S. Patent Covering ADAIR for the Treatment of Cognitive Impairment Associated with COVID-19finance.yahoo.com - February 28 at 11:58 AMVallon Pharmaceuticals reports FY resultsseekingalpha.com - February 14 at 7:45 PMVallon Pharmaceuticals Reports Fiscal Year 2021 Financial Results and Provides Business Updatefinance.yahoo.com - February 14 at 7:45 PMEven with Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) stock down 13% this week, insiders who bought recently netted around US$20kfinance.yahoo.com - January 25 at 12:42 PMmarketbeat.com - January 24 at 11:07 AMVallon Pharmaceuticals to Present at the Virtual Investor 2022 Top Picks Conferencefinance.yahoo.com - January 20 at 8:54 AMVallon Pharmaceuticals Presents New Data from Adult Stimulant Abuse Pattern Survey at the APSARD 2022 Annual Conferencefinance.yahoo.com - January 18 at 10:44 AMVallon Pharmaceuticals Inc Shares Close the Week 25.6% Higher - Weekly Wrapnasdaq.com - January 10 at 7:36 PM Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. VLON Media Mentions By Week VLON Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VLON News Sentiment▼0.000.33▲Average Medical News Sentiment VLON News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VLON Articles This Week▼00▲VLON Articles Average Week Get Vallon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VCNX News ATXI News XBIO News HOTH News ADXS News AIMD News FWBI News KZIA News SHPH News ENVB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VLON) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsTrump is sounding the alarmPreserve Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vallon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
